Abemaciclib metabolite M18 (LSN3106729), the metabolite of Abemaciclib, is a CDK inhibitor with antitumor activity. Abemaciclib metabolite M18 and a CRBN ligand have been used to design PROTAC CDK4/6 degrader.
Usually ships within 24 hours.